Start with three questions: what product is being applied, what will contact the skin, and what intended use does its documentation describe? Do not turn a reassuring name, a dark stain, an adhesive backing or a home skin test into a safety verdict. Compare documented answers—and keep unanswered questions visible.
The U.S. FDA distinctions that matter
FDA distinguishes direct-transfer decals from adhesive-backed types; backing does not eliminate concerns about other ingredients. In the United States, henna is approved for hair dye, not direct skin application. Black henna often involves PPD, which is not permitted in cosmetics intended for skin application. Retail cosmetics require ingredient declarations; samples and professional-only products are outside that requirement. The FDA temporary-tattoo fact sheet also suggests trying a decal on a less conspicuous area before facial use. That suggestion is not safety certification or permission for a restricted use.
The FDA tattoo safety Q&A reports allergic reactions to some temporary tattoos and skin injuries associated with products marketed as henna or black henna. Temporary does not mean reaction-free.
A comparison worksheet—not a safety ranking
The following table is an editorial question framework. It does not rank these categories or establish that a particular product is suitable for anyone.
| Product presented | Clarify skin contact | Request documentation | Keep unresolved |
|---|---|---|---|
| Decal or transfer | Which parts touch skin: image, backing, adhesive or another layer? | Ingredient information and directions for the exact item, including the proposed application area. | Does the information account for every contacting component, rather than just the printed image? |
| Henna or mehndi | What exact mixture will be applied? | Original packaging, ingredient information and stated intended use. | Is the answer about the actual mixture, or only about henna as a general category? |
| Black henna | What exact product or mixture creates the dark stain? | Product identity, ingredients, any additions and intended-use directions. | Is composition documented, or inferred solely from the name and resulting color? |
Turn vendor answers into a usable record
- Identify the item. Write down the product name and whether the answer concerns a sealed packet, a cone or a prepared mixture. A general description of the service is not an answer about the item.
- Connect the paperwork. Ask whether the package or leaflet shown belongs to the material being applied. If that connection cannot be established, mark it unresolved rather than borrowing another product’s information.
- Separate ingredients from intended use. Record both. An ingredient answer does not resolve an application-use question; a claim about hair use does not answer a skin-use question.
- Record missing information accurately. Distinguish information not supplied from an ingredient confirmed absent. Neither a verbal assurance nor silence should fill an empty entry.
- Choose a documentation threshold. Before comparing options, decide which unanswered questions would make you pause the decision. This is an information rule, not a medical suitability assessment.
What appearance and a home test cannot settle
Natural branding is not a composition record. A brown or black stain is not an ingredient declaration. A visible backing is not documentation for every component. Treat these as clues for questions, not substitutes for answers.
Similarly, do not record a home skin test as proof of overall safety or permitted use. A personal observation and a regulatory intended-use restriction answer different questions. This worksheet does not recommend a testing procedure or interpret a skin response.
A hypothetical comparison
Hypothetical example: One vendor shows an adhesive-backed decal with matching paperwork. Another offers a dark paste described only as natural. The first answer documents more about identity; it does not establish safety. The second leaves composition unresolved. Record those differences without converting either into a prediction about reactions or a recommendation for a particular person.
Source date and limits
This article uses FDA excerpts captured October 23, 2026, UTC. It is source-based guidance about U.S. regulatory distinctions, not firsthand testing or a live product check. The excerpts cannot establish an individual product’s composition, compliance or safety. Refresh the guidance if FDA changes its intended-use restrictions or labeling explanations; obtain new documentation when the product or mixture changes.
